[ad_1] The upcoming GST council meeting is likely to provide relief on a slew of cancer drugs, sources with knowledge of the matter told CNBC-TV18. Sources further said that the GST council nominated fitment committee is likely to reduce GST on cancer drugs like Trastuzumab Deruxtecan, Osimertinib, Durvalumab to 5% from the current levels of […]
Biocon arm Biocon Pharma receives US FDA approval for Daptomycin injection – CNBC TV18
[ad_1] Biotechnology firm Biocon Ltd on Friday (August 30) said its wholly owned subsidiary Biocon Pharma Ltd has received approval from the US Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) for Daptomycin for injection (500mg vial). “This is to inform you that Biocon Pharma Limited, a wholly-owned subsidiary of […]
Biocon receives FDA report, can start supplies to US from Vizag facility – CNBC TV18
[ad_1] Biotechnology firm Biocon Ltd on Friday (August 30) said it has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (US FDA) for its greenfield active pharmaceutical ingredient (API) facility, Site 6, in Visakhapatnam, Andhra Pradesh. “This is to inform you that the Company has received an Establishment Inspection Report […]
Biocon Q1 Results | Net profit zooms 6-fold to ₹660 crore, revenue flat and below estimates – CNBC TV18
[ad_1] Biotechnology firm Biocon Ltd on Thursday (August 8) reported a 550.59% year-on-year (YoY) jump in net profit at ₹659.7 crore for the first quarter that ended June 30, 2024. In the corresponding quarter, Biocon posted a net profit of ₹101.4 crore, the company said in a regulatory filing. The CNBC-TV18 poll had predicted a […]
CNBC-TV18 accesses USFDA observations for Biocon Biologics unit. Details here – CNBC TV18
[ad_1] CNBC-TV18 has accessed the observations that the US Food & Drug Administration (USFDA) has issued to Biocon Biologics’ Units. The facility was inspected by the regulator between July 15 – July 19, and July 22 – July 26, post which, the observations were issued along with the form-483. Observations issued by USFDA: – Procedures […]
Biocon gets US FDA report after Vizag facility scan; no more regulatory action needed – CNBC TV18
[ad_1] Biotechnology firm Biocon Ltd on Monday (August 5) said it has received an establishment inspection report (EIR) with voluntary action indicated (VAI) from the US Food and Drug Administration (FDA) for its active pharmaceutical ingredient (API) facility located at Visakhapatnam, Andhra Pradesh. “This is to inform you that the Company has received an Establishment […]